# Autologous Plasma Rich in Growth Factors (PRGF) Treating the Symptomatic Knee OA

> **NCT00782197** · PHASE4 · COMPLETED · sponsor: **Biotechnology Institute IMASD** · enrollment: 240 (estimated)

## Conditions studied

- Joint Disease

## Interventions

- **DEVICE:** PRGF Intraarticular injection
- **DEVICE:** Hyaluronic Acid Intraarticular injection

## Key facts

- **NCT ID:** NCT00782197
- **Lead sponsor:** Biotechnology Institute IMASD
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2010-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00782197

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00782197, "Autologous Plasma Rich in Growth Factors (PRGF) Treating the Symptomatic Knee OA". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00782197. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*